Med-X Statistics
Total Valuation
Med-X has a market cap or net worth of $27.77 million. The enterprise value is $28.31 million.
| Market Cap | 27.77M |
| Enterprise Value | 28.31M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Med-X has 5.55 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 5.55M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 26.83 |
| Forward PS | n/a |
| PB Ratio | 18.52 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 27.35 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | 1.87 |
| Debt / Equity | 0.77 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5,699.21 |
Financial Efficiency
Return on equity (ROE) is -505.15% and return on invested capital (ROIC) is -285.09%.
| Return on Equity (ROE) | -505.15% |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | -285.09% |
| Revenue Per Employee | $64,691 |
| Profits Per Employee | -$350,202 |
| Employee Count | 16 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Med-X had revenue of $1.04 million and -$5.60 million in losses. Loss per share was -$1.01.
| Revenue | 1.04M |
| Gross Profit | 225,063 |
| Operating Income | -7.57M |
| Pretax Income | -7.58M |
| Net Income | -5.60M |
| EBITDA | -7.53M |
| EBIT | -7.57M |
| Loss Per Share | -$1.01 |
Balance Sheet
The company has $619,284 in cash and $1.16 million in debt, giving a net cash position of -$537,824 or -$0.10 per share.
| Cash & Cash Equivalents | 619,284 |
| Total Debt | 1.16M |
| Net Cash | -537,824 |
| Net Cash Per Share | -$0.10 |
| Equity (Book Value) | 1.50M |
| Book Value Per Share | 0.27 |
| Working Capital | 1.29M |
Cash Flow
In the last 12 months, operating cash flow was -$5.40 million and capital expenditures -$86,377, giving a free cash flow of -$5.49 million.
| Operating Cash Flow | -5.40M |
| Capital Expenditures | -86,377 |
| Free Cash Flow | -5.49M |
| FCF Per Share | -$0.99 |
Margins
Gross margin is 21.74%, with operating and profit margins of -731.78% and -541.35%.
| Gross Margin | 21.74% |
| Operating Margin | -731.78% |
| Pretax Margin | -731.90% |
| Profit Margin | -541.35% |
| EBITDA Margin | -727.91% |
| EBIT Margin | -731.78% |
| FCF Margin | -530.12% |
Dividends & Yields
Med-X does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -20.18% |
| FCF Yield | -19.76% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |